(株)リボミックの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4591/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/08/28 | 日証協 | 445,100株 | -19.66% | 45,500株 | -23.4% | 374,423株 | -9.8% | 67,220株 | +846.76% |
| 2015/08/21 | 日証協 | 554,000株 | +3.3% | 59,400株 | +25.58% | 415,123株 | +2.02% | 7,100株 | -56.97% |
| 2015/08/14 | 日証協 | 536,300株 | +1.69% | 47,300株 | +13.16% | 406,923株 | +1.42% | 16,500株 | -17.91% |
| 2015/08/07 | 日証協 | 527,400株 | +5.02% | 41,800株 | -4.13% | 401,223株 | +2.61% | 20,100株 | -33.93% |
| 2015/07/31 | 日証協 | 502,200株 | +6.99% | 43,600株 | +93.78% | 391,003株 | -11.88% | 30,420株 | +118.38% |
| 2015/07/24 | 日証協 | 469,400株 | +15.79% | 22,500株 | -70% | 443,703株 | +6.93% | 13,930株 | -63.97% |
| 2015/07/17 | 日証協 | 405,400株 | -15.98% | 75,000株 | +393.42% | 414,943株 | -3.78% | 38,660株 | -17.59% |
| 2015/07/10 | 日証協 | 482,500株 | +0.75% | 15,200株 | -90.96% | 431,253株 | -3.55% | 46,910株 | -46.93% |
| 2015/07/03 | 日証協 | 478,900株 | +2.5% | 168,200株 | +87.31% | 447,143株 | +8.84% | 88,400株 | +4.62% |
| 2015/06/26 | 日証協 | 467,200株 | +15.47% | 89,800株 | -0.77% | 410,843株 | +14.4% | 84,500株 | +3.94% |
| 2015/06/19 | 日証協 | 404,600株 | +1.35% | 90,500株 | +85.07% | 359,143株 | +6.59% | 81,300株 | +71.85% |
| 2015/06/12 | 日証協 | 399,200株 | -6.2% | 48,900株 | -32.46% | 336,938株 | -1.58% | 47,310株 | -12.41% |
| 2015/06/05 | 日証協 | 425,600株 | +15.97% | 72,400株 | +56.71% | 342,338株 | +9.6% | 54,010株 | +52.92% |
| 2015/05/29 | 日証協 | 367,000株 | 0% | 46,200株 | 0% | 312,338株 | 0% | 35,320株 | 0% |
| 2015/05/15 | 日証協 | 374,500株 | +2.69% | 10,200株 | +292.31% | 335,338株 | +1.95% | 12,530株 | +381.92% |
| 2015/05/08 | 日証協 | 364,700株 | -0.25% | 2,600株 | +225% | 328,929株 | +0.49% | 2,600株 | -47.06% |
| 2015/05/01 | 日証協 | 365,600株 | -1.24% | 800株 | -77.14% | 327,318株 | -1.12% | 4,911株 | +44.44% |
| 2015/04/24 | 日証協 | 370,200株 | -1.86% | 3,500株 | -2.78% | 331,018株 | -1.84% | 3,400株 | -30.61% |
| 2015/04/17 | 日証協 | 377,200株 | -11.52% | 3,600株 | +350% | 337,218株 | -9.74% | 4,900株 | -89.11% |
※株式分割は考慮していませんのでご注意ください。
Page Top